Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer

被引:83
|
作者
Fletcher, Matthew [1 ]
Hodgkiss, Hailey [2 ]
Zhang, Song [3 ]
Browning, Rachel [2 ]
Hadden, Colleen [2 ]
Hoffman, Tanja [2 ]
Winick, Naomi [2 ,4 ]
McCavit, Timothy L. [2 ,4 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Div Hematol Oncol, Dept Pediat, New Orleans, LA USA
[2] Childrens Med Ctr Dallas, Ctr Canc & Blood Disorders, Dallas, TX USA
[3] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Div Hematol Oncol, Dept Pediat, Dallas, TX 75390 USA
关键词
febrile neutropenia; prevalence; quality-of-care; time-to-antibiotics; QUALITY-OF-CARE; ANTIMICROBIAL AGENTS; SEVERE SEPSIS; MANAGEMENT; THERAPY; MORTALITY; DELAY; MENINGITIS; BACTEREMIA; GUIDELINES;
D O I
10.1002/pbc.24485
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Time-to-antibiotic (TTA) administration is a widely used quality-of-care measure for children with cancer and febrile neutropenia (FN). We sought to determine whether TTA is associated with outcomes of FN. Procedure A single-center, retrospective cohort study was conducted of 1,628 FN admissions from 653 patients from 2001 to 2009. Outcome variables included (1) an adverse event (AE) composite of in-hospital mortality, pediatric intensive care unit (PICU) admission within 24hours of presentation, and/or fluid resuscitation 40ml/kg within 24hours of presentation and (2) length of stay (LOS). TTA was measured as a continuous variable and in 60-minute intervals. Mixed regression models were constructed to evaluate associations of TTA with the outcome variables after adjusting for relevant covariates including cancer diagnosis, degree of myelosuppression, and presence of bacteremia. Results The composite AE outcome occurred in 11.1% of admissions including 0.7% in-hospital mortality, 4.7% PICU admission, and 10.1% fluid resuscitation. In univariate analysis, TTA was associated with the composite AE outcome (Odds Ratio [OR] 1.29, 95% CI 1.02-1.64) but not LOS. In multivariate analysis, after adjustment for relevant covariates, 60-minute TTA intervals were associated with the composite AE outcome (61-120minutes vs. 60minutes, OR 1.81, 95% CI 1.01-3.26). Unexpectedly, admission from the emergency department (ED) was also independently associated with the composite AE outcome (ED vs. clinic, OR 3.15, 95% CI 1.95-5.09). Conclusions TTA and presentation to the ED are independently associated with poor outcomes of FN. Pediatr Blood Cancer 2013;60:1299-1306. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:1299 / 1306
页数:8
相关论文
共 50 条
  • [1] ANTIBIOTICS FOR THE TREATMENT OF FEBRILE CHILDREN WITH NEUTROPENIA AND CANCER
    RUBIN, M
    PIZZO, PA
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (14): : 939 - 939
  • [2] Time to antibiotics and outcomes in cancer patients with febrile neutropenia
    Perron, Thomas
    Emara, Mohamed
    Ahmed, Shahid
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [3] Time to antibiotics and outcomes in cancer patients with febrile neutropenia
    Thomas Perron
    Mohamed Emara
    Shahid Ahmed
    BMC Health Services Research, 14
  • [4] Febrile Neutropenia in Children with Cancer
    Paulus, Stephane
    Dobson, Simon
    HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN V, 2009, 634 : 185 - 204
  • [5] IMPACT OF REPORTED FEVER ON OUTCOMES OF FEBRILE NEUTROPENIA IN CHILDREN WITH CANCER
    Dias, Nechelle
    Pastor, Erin
    Smith, Sharon
    Nowobilski, Mary-Kate
    Orsey, Andrea
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S28 - S28
  • [6] Time-to-Antibiotics (TTA) and outcomes in cancer patients with febrile neutropenia (FN)
    Perron, T.
    Ahmed, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S316 - S316
  • [7] Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?
    Butters, Coen
    Thursky, Karin
    Hanna, Diane T.
    Cole, Theresa
    Davidson, Andrew
    Buttery, Jim
    Haeusler, Gabrielle
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (03) : 267 - 279
  • [8] PREDICTORS FOR ADVERSE OUTCOMES IN CHILDREN WITH FEBRILE NEUTROPENIA
    Pakakasama, S.
    Puttiaungkoon, N.
    Okascharoen, C.
    Surayuthpreecha, K.
    Sirachainan, N.
    Hongeng, S.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 170 - 170
  • [9] Length of stay and mortality associated with febrile neutropenia among children with cancer
    Basu, SK
    Fernandez, ID
    Fisher, SG
    Asselin, BL
    Lyman, GH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 7958 - 7966
  • [10] Study of mortality associated with febrile neutropenia among children with cancer.
    Basu, SK
    Fernandez, ID
    Fisher, SG
    Asselin, BL
    Lyman, GH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 805S - 805S